Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Pharmacokinetics

12 evidence topics · 13 sources

Food effect study of DT120 ODT: treatment-emergent adverse events by cohort
MeasureDT120 ODT + high-fat meal (n = 31)DT120 ODT + low-fat meal (n = 28)
Any TEAE“31 (100.0)”“28 (100.0)”
TEAE leading to treatment withdrawal“1 (3.2)”“2 (7.1)”
Mild“24 (77.4)”“22 (78.6)”
Moderate“7 (22.6)”“5 (17.9)”
Severe“0”“1 (3.6)”
Any related TEAE“31 (100.0)”“28 (100.0)”
Absorption, peak concentration, and half-life of oral LSD